Tech Company Financing Transactions
Odyssey Therapeutics Funding Round
On 12/5/2023, Odyssey Therapeutics raised $101 million in Series C investment from Ascenta Capital, BlackMars Capital and Colt Ventures.
Transaction Overview
Company Name
Announced On
12/5/2023
Transaction Type
Venture Equity
Amount
$101,000,000
Round
Series C
Investors
Proceeds Purpose
The company intends to use the funds to support the advancement of multiple programs into clinical studies and the continuation of investment in discovery to build a sustainable model for therapeutic innovation.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Cambridge office: 301 Binney St
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Overview
Odyssey is pioneering next generation precision immunomodulators and oncology medicines for patients through our industry leading discovery engine. We have ambitious goals, and we aim to reach them by breaking down barriers and challenging the status quo.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gary Glick
Co-Founder
Felix Meissner
Co-Founder
David Pompliano
Browse more venture capital transactions:
Prev: 12/5/2023: UP Catalyst venture capital transaction
Next: 12/5/2023: sipMARGS venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to document funding rounds that are announced publicly. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs